WAYNE, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it was awarded the Peripheral Access purchasing agreement with Premier, Inc. Effective December 1st, 2023, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Teleflex's Peripheral Access products. Premier has awarded Teleflex a national multi-source agreement for Peripherally Inserted Central Catheters (PICCs), PICC navigation equipment, and Midlines.
"Teleflex strives to deliver vascular access products that are designed to benefit both clinicians and patients, while helping to protect against vascular access related complications1-7," said Lisa Kudlacz, President and General Manager, Teleflex Vascular. "We are pleased to continue to support Premier members with these PICC, Midline and Navigation products. Arrow™ PICCs and Midlines are available in a traditional design or with Arrowg+ard Blue Advance™ Protection Technology that's proven effective to reduce catheter colonization by the major central line associated blood stream infection (CLABSI) causing pathogens."2-7
Teleflex, through its Arrow™ Peripheral Access products, has recently refreshed the portfolio to help healthcare providers optimize patient outcomes, reduce catheter colonization of the major central line-associated infections (CLABSI) causing pathogens, and efficiently streamline insertion procedures1-7.
The group purchasing agreement includes access to the:
- Arrow™ VPS Rhythm DLX™ Device capital equipment portfolio for PICC placements
- Arrow™ PICCs preloaded with the NaviCurve™ Stylet
- Arrow™ VPS G4™ Capital Equipment portfolio for PICC placements
- Traditional Arrow™ PICCs
- Arrowg+ard Blue Advance™ Antimicrobial/Antithrombogenic PICCs
- Traditional Arrow™ Midlines
- Arrowg+ard Blue Advance™ Antimicrobial/Antithrombogenic Midlines
- Arrow™ Twin Cath™ Peripheral Catheters
- Peripheral Access accessories
Teleflex is committed to supporting vascular access specialists in their efforts to reduce vascular-related complications by offering the world's first antimicrobial and antithrombogenic PICCs and Midlines.3,7
Utilizing Arrowg+ard Blue Advance™ PICCs and Midlines guards against CLABSI-causing pathogens in areas that are clinically out of reach.3,7 This protection lasts while the line is in the ...